Pharma Journalist -

CASI Pharmaceuticals, Inc. announces that it has acquired a U.S. FDA-approved abbreviated new drug application (ANDA) from Laurus Labs Limited. The drug, tenofovir disoproxil fumarate…
Read More...

FSD Pharma Inc. announced the signing of a binding letter of intent (the “LOI”) to acquire Therapix Biosciences Ltd. effective October 22, 2018. The Transaction (the “Transaction”)…
Read More...

Purdue Pharma L.P. and SpineThera, Inc. announced that the companies have entered into an agreement that provides Purdue the exclusive option to acquire SpineThera, Inc. and gain…
Read More...

Orgenesis Inc. announced it has entered into a collaboration agreement with Hemogenyx Pharmaceuticals Plc (LSE: HEMO) to collaborate on the development and commercialization of…
Read More...

Vertex Pharmaceuticals (Europe) Limited announces that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for…
Read More...

LSK BioPharma and Jiangsu Hengrui Medicine announced that the companies have entered into a global clinical collaboration in patients with advanced hepatocellular carcinoma (HCC),…
Read More...

Pfizer Inc. announced detailed overall survival (OS) data from the PALOMA-3 trial, which evaluated IBRANCE (palbociclib) in combination with fulvestrant compared to placebo plus…
Read More...

The U.S. Food and Drug Administration has approved Dupixent (dupilumab) as an add-on maintenance therapy in patients with moderate-to-severe asthma aged 12 years and older with an…
Read More...

Amneal Pharmaceuticals announced that it has received FDA approval for a generic version of BiCNU (carmustine) for injection, 100 mg. The Company is planning to commercialize its…
Read More...

apceth Biopharma GmbH announced positive results for apceth-201 in mouse models for acute graft-versus-host disease (aGvHD). The data was highlighted in a poster presentation at the…
Read More...